↓ Skip to main content

Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study

Overview of attention for article published in Arthritis Research & Therapy, January 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter
googleplus
1 Google+ user

Citations

dimensions_citation
51 Dimensions

Readers on

mendeley
52 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study
Published in
Arthritis Research & Therapy, January 2013
DOI 10.1186/ar4350
Pubmed ID
Authors

Dinny Wallis, Arundip Asaduzzaman, Michael Weisman, Nigil Haroon, Ammepa Anton, Dermot McGovern, Stephan Targan, Robert Inman

Abstract

Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) share genetic and clinical features. IBD is associated with the presence of antibodies to a variety of commensal microorganisms including anti-Saccharomyces cerevesiae antibodies (ASCA), antineutrophil cytoplasmic antibodies (ANCA), anti-I2 (associated with anti-Pseudomonas activity), anti-Eschericia coli outer membrane porin C (anti-OmpC) and anti-flagellin antibodies (anti-CBir1). Subclinical intestinal inflammation may be present in up to 65% of patients with AS. This study evaluated the presence of antimicrobial antibodies in patients with AS alone, patients with AS and concomitant IBD (AS-IBD) and a control group of patients with mechanical back pain (MBP).

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 52 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 2%
Spain 1 2%
Greece 1 2%
Unknown 49 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 15%
Other 6 12%
Researcher 6 12%
Student > Ph. D. Student 6 12%
Student > Doctoral Student 6 12%
Other 13 25%
Unknown 7 13%
Readers by discipline Count As %
Medicine and Dentistry 26 50%
Agricultural and Biological Sciences 8 15%
Biochemistry, Genetics and Molecular Biology 4 8%
Immunology and Microbiology 2 4%
Nursing and Health Professions 1 2%
Other 2 4%
Unknown 9 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2018.
All research outputs
#7,441,034
of 12,341,908 outputs
Outputs from Arthritis Research & Therapy
#1,276
of 1,962 outputs
Outputs of similar age
#93,487
of 196,771 outputs
Outputs of similar age from Arthritis Research & Therapy
#20
of 31 outputs
Altmetric has tracked 12,341,908 research outputs across all sources so far. This one is in the 37th percentile – i.e., 37% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,962 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 196,771 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 32nd percentile – i.e., 32% of its contemporaries scored the same or lower than it.